iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Short Interest Down 82.8% in December

iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) was the recipient of a large decrease in short interest in December. As of December 15th, there was short interest totaling 9,491 shares, a decrease of 82.8% from the November 30th total of 55,051 shares. Based on an average daily trading volume, of 25,599 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.2% of the shares of the company are sold short. Approximately 0.2% of the shares of the company are sold short. Based on an average daily trading volume, of 25,599 shares, the days-to-cover ratio is currently 0.4 days.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in IDNA. Triumph Capital Management bought a new position in iShares Genomics Immunology and Healthcare ETF during the 3rd quarter worth $35,000. Flow Traders U.S. LLC acquired a new stake in shares of iShares Genomics Immunology and Healthcare ETF in the second quarter valued at about $931,000. Ameriprise Financial Inc. raised its position in shares of iShares Genomics Immunology and Healthcare ETF by 8.4% during the third quarter. Ameriprise Financial Inc. now owns 71,473 shares of the company’s stock worth $1,688,000 after acquiring an additional 5,540 shares during the last quarter. Finally, Portland Global Advisors LLC acquired a new position in shares of iShares Genomics Immunology and Healthcare ETF in the second quarter worth approximately $2,099,000.

iShares Genomics Immunology and Healthcare ETF Price Performance

iShares Genomics Immunology and Healthcare ETF stock traded up $0.15 during midday trading on Thursday, hitting $26.94. The company’s stock had a trading volume of 8,171 shares, compared to its average volume of 29,506. The company has a market cap of $136.05 million, a price-to-earnings ratio of 14.76 and a beta of 1.07. iShares Genomics Immunology and Healthcare ETF has a 1-year low of $17.26 and a 1-year high of $27.65. The company has a 50-day moving average price of $25.97 and a two-hundred day moving average price of $23.49.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.